Principal Financial Group’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $848K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $132K | Sell |
|
|||||
|
2023
Q4 | $184K | Sell |
|
|||||
|
2023
Q3 | $161K | Buy |
|
|||||
|
2023
Q2 | $175K | Sell |
|
|||||
|
2023
Q1 | $189K | Sell |
|
|||||
|
2022
Q4 | $208K | Buy |
|
|||||
|
2022
Q3 | $180K | Buy |
|
|||||
|
2022
Q2 | $160K | Buy |
|
|||||
|
2022
Q1 | $101K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $184K | Buy |
|
|||||
|
2021
Q2 | $216K | Buy |
|
|||||
|
2021
Q1 | $288K | Sell |
|
|||||
|
2020
Q4 | $422K | Buy |
|
|||||
|
2020
Q3 | $171K | Sell |
|
|||||
|
2020
Q2 | $255K | Buy |
|
|||||
|
2020
Q1 | $200K | Buy |
|
|||||
|
2019
Q4 | $214K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $202K | Sell |
|
|||||
|
2018
Q3 | $478K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $235K | Buy |
|
|||||
|
2017
Q4 | $246K | Buy |
|
|||||
|
2017
Q3 | $294K | Sell |
|
|||||
|
2017
Q2 | $571K | Buy |
|
|||||
|
2017
Q1 | $420K | Buy |
|